Preview

Современная ревматология

Расширенный поиск

Часть I. Поражение дыхательной системы у пациентов с ревматоидным артритом

https://doi.org/10.14412/1996-7012-2013-2440

Полный текст:

Аннотация

23–25 мая 2013 г. в Каролинском институте (Стокгольм, Швеция) при поддержке Компании MSD была проведена Клиническая обсервационная программа для врачей-ревматологов, в которой приняли участие известные ревматологи и ведущие специалисты института проф. R. van Vollenhoven, проф. L. Klareskog, д-р. E. af Klint, д-р. C. Carlens. В докладах и на интерактивных сессиях обсуждались проблемы ревматоидного артрита (РА), в том числе раннего РА (этиология, патогенез, лечение), регистры пациентов с ревматическими заболеваниями, УЗИ-диагностика воспалительных заболеваний опорно-двигательного аппарата, биологическая терапия ревматических заболеваний, организация работы исследовательской иммунологической лаборатории, поликлинического отделения и отделения дневного стационара в ревматологической клинике. Программу посетили врачи из различных стран Европы (Швеция, Германия, Франция, Россия, Испания, Греция и др.). Ниже представлен обзор материалов Клинической обсервационной программы.

Об авторе

Р. Р. Самигуллина
ГБОУ ВПО «Северо-Западный государственный медицинский университет им. И.И. Мечникова», Санкт-Петербург
Россия


Литература

1. <div><p>Turesson C, O’Fallon WM, Crowson CS et al. Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years. Ann Rheum Dis. 2003;62(8):722–7.</p><p>Turesson C, Jacobsson LT. Epidemiology of extra-articular manifestations in rheumatoid arthritis. Scand J Rheumatol. 2004;33(2):65–72. DOI: http://dx.doi.org/10.1080%2F03009740310004621.</p><p>Minaur NJ, Jacoby RK, Cosh JA et al. Outcome after 40 years with rheumathoid arthritis: a prospective study of function, disease activity, and mortality. J Rheumatol Suppl. 2004;69:3–8.</p><p>Sihvonen S, Korpela M, Laipalla P et al. Death rates and causes of death in patients with rheumathoid arthritis: a population-based study. Scand J Rheumatol. 2004;33(4):221–7. DOI: http://dx.doi.org/10.1080%2F03009740410005845.</p><p>Suzuki A, Ohosone Y, Obana M et al. Cause of death in 81 autopsied patients with rheumathoid arthritis. J Rheumatol. 1994;21(1):33–6.</p><p>Gabriel SE, Crowson CS, Kremers HM et al. Survival in rheumatoid arthritis: a populationbased analysis of trends over 40 years. Arthritis Rheum. 2003;48(1):54–8.</p><p>Maradit-Kremers H, Nicola PJ, Crowson CS et al. Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum. 2005;52(3):722–32. DOI: http://dx.doi.org/10.1002%2Fart.20878.</p><p>Мазуров ВИ, Богданов АН. Поражение легких при диффузных заболеваниях соединительной ткани. Санкт-Петербург: ООО «Агентство РДК-Принт»; 2002. 120 с. [Mazurov VI, Bogdanov AN. Porazhenie legkikh pri diffuznykh zabolevaniyakh soedinitel'noy tkani. St-Petersburg: OOO «Agentstvo RDK-Print»; 2002. 120 p.]</p><p>Zrour SH, Touzi M, Bejia I et al. Correlations between high-resolution computed tomography of the chest and clinical function in patients with rheumatoid arthritis: prospective study in 75 patients. Joint Bone Spine. 2005;72(1):41–7.</p><p>Bilgici A, Ulusoy H, Kuru O et al. Pulmonary involvement in rheumatoid arthritis. Rheumatol Int. 2005;25(6):429–35. DOI: http://dx.doi.org/10.1007%2Fs00296-004-0472-y.</p><p>Насонов ЕЛ, Насонова ВА. Ревматология: Национальное руководство. Москва: ГЭОТАР-Медиа; 2008. 737 с. [Nasonov EL, Nasonova VA. Revmatologiya: Natsional'noe rukovodstvo. Moscow: GEOTAR-Media; 2008. 737 p.]</p><p>Byrd SL, Case BA, Boulware DW. Pulmonary manifestations of rheumatic disease. Postgrad Med. 1993;93(1):149–51,154–6, 159–61.</p><p>Boulware DW, Weissman DN, Doll NJ. Pulmonary manifestations of the rheumatic diseases. Clin Rev Allergy.1985;3(2):249–67. DOI: http://dx.doi.org/10.1007%2FBF02992987.</p><p>Morrison SC, Mody GM, Benatar SR, Meyers OL. The lungs in rheumatoid arthritis– a clinical, radiographic and pulmonary function study. S Afr Med J. 1996;86(7):829–33.</p><p>Walker WC. Pulmonary manifestations of the rheumatic diseases. Practitioner. 1978;220(1315):51–5.</p><p>Lipsky P. Rheumatoid arthritis. In: Fauci AS, Harrison TR, editors. Harrison’s principles of internal medicine.14th ed. New York: McGraw-Hill; 1998.1880–8.</p><p>Pettersson T, Soderblom T, Nyberg P et al. Pleural fluid soluble interleukin 2 receptor in rheumatoid arthritis and systemic lupus erythematosus. J Rheumatol. 1994;21(10):1820–4.</p><p>Nyberg P, Soderblom T, Pettersson T et al. Neurone-specific enolase levels in pleural effusions in patients with rheumatoid arthritis. Thorax. 1996;51(1):92–4. DOI: http://dx.doi.org/10.1136%2Fthx.51.1.92.</p><p>Turner-Stokes L, HaslamP, Jones M et al. Autoantibody and idiotype profile of lung involvement in autoimmune rheumatic disease. Ann Rheum Dis. 1990;49(3):160–2. DOI: http://dx.doi.org/10.1136%2Fard.49.3.160.</p><p>Lamblin C, Bergoin C, Saelens T, Wallaert B. Interstitial lung diseases in collagen vascular diseases. EurRespir J. 2001;32:69s–80s.</p><p>Dawson JK, Fewins HE, Desmond J et al. Fibrosingalveolitis in patients with rheumatoid arthritis as assessed by high resolution computed tomography, chest radiography, and pulmonary function tests. Thorax. 2001;56(8):622–7.</p><p>Kim EJ, Collard HR, King TE Jr. Rheumatoid arthritis-associated interstitial lung disease: the relevance of histopathologic and radiographic pattern. CHEST. 2009; 136(5):1397-405. DOI: 10.1378/chest.09-0444.</p><p>Hunninghake GW, Zimmerman MB, Schwartz DA et al. Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2001;164(2):193–6.</p><p>American Thoracic Society, European Respiratory Society. American Thoracic Society/European Respiratory Society International multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respi rCrit Care Med. 2002;165:277–304.</p><p>Tanaka N, Kim JS, Newell JD et al. Rheumatoid arthritis-related lung diseases: CT findings. Radiology. 2004;232(1):81–91. DOI: http://dx.doi.org/10.1148%2Fradiol.2321030174.</p><p>Hakala M. Poor prognosis in patients with rheumatoid arthritis hospitalized for interstitial lung fibrosis. Chest. 1988;93(1):114–8. DOI: http://dx.doi.org/10.1378%2Fchest.93.1.114.</p><p>Banks J, Banks C, Cheong B et al. An epidemiological and clinical investigation of pulmonary function and respiratory symptoms in patients with rheumatoid arthritis. Q J Med. 1992;85:795–806.</p><p>Vassallo R, Matteson E, Thomas CF Jr. Clinical response of rheumatoid arthritis-associated pulmonary fibrosis to tumor necrosis factor-alpha inhibition. Chest. 2002;122(3):1093–6.</p><p>Kolarz G, Scherak O, Popp W et al. Bronchoalveolar lavage in rheumatoid arthritis. Br J Rheumatol. 1993;32(7):556–61. DOI: http://dx.doi.org/10.1093%2Frheumatology%2F32.7.556.</p><p>Geddes DM, Corrin B, Brewerton DA et al. Progressiveairway obliteration in adults and its association withrheumatoid disease. Q J Med. 1977;46(184):427–44.</p><p>Tanoue LT. Pulmonary manifestations of rheumatoid arthritis. Clin Chest Med. 1998;19(4):667–85. DOI: http://dx.doi.org/10.1016%2FS0272-5231%2805%2970109-X.</p><p>Bayar N, Kara SA, Keles I et al. Cricoarytenoiditis in rheumatoid arthritis: radiologic and clinical study. J Otolaryngol. 2003;32(06):373–8. DOI: http://dx.doi.org/10.2310%2F7070.2003.13910.</p><p>Klareskog L, Stolt P, Lundberg K et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope) – restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum. 2006;54(1):38–46. DOI: http://dx.doi.org/10.1002%2Fart.21575.</p><p>Vessey MP, Villard-Mackintosh L, Yeates D. Oral contraceptives, cigarette smoking and other factors in relation to arthritis. Contraception. 1987;35(5):457–64. DOI: http://dx.doi.org/10.1016%2F0010-7824%2887%2990082-5.</p><p>Silman AJ, Newman J, MacGregor AJ. Cigarette smoking increases the risk of rheumatoid arthritis: results from a nationwide study of disease-discordant twins. Arthritis Rheum. 1996;39(5):732–5. DOI: http://dx.doi.org/10.1002%2Fart.1780390504.</p><p>Heliovaara M, Aho K, Aromaa A et al. Smoking and risk of rheumatoid arthritis. J Rheumatol. 1993;20(11):1830–5.</p><p>Uhlig T, Hagen KB, Kvien TK. Current tobacco smoking, formal education, and the risk of rheumatoid arthritis. J Rheumatol. 1999;26(1):47–54.</p><p>Stolt P, Bengtsson C, Nordmark B et al. Quantification of the influence of cigarette smoking on rheumatoid arthritis. Ann Rheum Dis. 2003;62(9):835–41. DOI: http://dx.doi.org/10.1136%2Fard.62.9.835.</p><p>Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis: an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum. 1987;30(11):1205–13. DOI: http://dx.doi.org/10.1002%2Fart.1780301102.</p><p>Jawaheer D, Gregersen PK. Rheumatoid arthritis: the genetic components. Rheum Dis Clin North Am. 2002;28(1):1–15. DOI: http://dx.doi.org/10.1016%2FS0889-857X%2803%2900066-8.</p><p>Padyukov L, Silva C, Stolt P et al. A gene–environment interaction between smoking and shared epitope genes in HLA–DR provides a high risk of seropositive rheumatoid arthritis. Arthritis Rheum. 2004;50(10):3085–92. DOI: http://dx.doi.org/10.1002%2Fart.20553.</p><p>Schellekens GA, Visser H, de Jong BA et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum. 2000;43(1):155–63. DOI: http://dx.doi.org/10.1002%2F1529-0131%28200001%2943%3A1%3C155%3A%3AAID-ANR20%3E3.0.CO%3B2-3.</p><p>Van Gaalen FA, van Aken J, Huizinga TW et al. Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis. Arthritis Rheum. 2004;50(7):2113–21. DOI: http://dx.doi.org/10.1002%2Fart.20316.</p><p>Hoffman IE, Peene I, Cebecauer L et al. Presence of rheumatoid factor and antibodies to citrullinated peptides in systemic lupus erythematosus. Ann Rheum Dis. 2005;64(2):330–2. DOI: http://dx.doi.org/10.1136%2Fard.2004.022111.</p><p>Rantapaa-Dahlqvist S, de Jong BA, Berglin E et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum. 2003;48(10):2741–9. DOI: http://dx.doi.org/10.1002%2Fart.11223.</p><p>Miettinen OS. Estimatibility and estimation in case-referent studies. Am J Epidemiol. 1976;103:226–35.</p><p>Rothman KJ, Greenland S, Walker AM. Concepts of interaction. Am J Epidemiol. 1980;112:467–70.</p><p>Hosmer DW, Lemeshow S. Confidence interval estimation of interaction. Epidemiology. 1992;3(5):452–6. DOI: http://dx.doi.org/10.1097%2F00001648-199209000-00012.</p><p>Cody RP, Smith JK. Applied statistics and the SAS programming language. 4th ed. Upper Saddle River (NJ): Prentice Hall; 1997.</p><p>Vossenaar ER, Radstake TR, van der Heijden A et al. Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages. Ann Rheum Dis. 2004;63(4):373–81. DOI: http://dx.doi.org/10.1136%2Fard.2003.012211.</p><p>Hill JA, Southwood S, Sette A et al. Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritisassociated HLA-DRB1*0401 MHC class II molecule. J Immunol. 2003;171:538–41.</p><p>Nielen MM, van Schaardenburg D, Reesink HW et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum. 2004;50(2):380–6.</p><p>Aho K, Palosuo T, Heliovaara M et al. Antifilaggrin antibodies within “normal” range predict rheumatoid arthritis in a linear fashion. J Rheumatol. 2000;27:2743–6.</p><p>Berglin E, Padyukov L, Sundin U et al. A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB 1 locus antigens is strongly associated with future onset of rheumatoid arthritis. Arthritis Res Ther. 2004;6:R303–8.</p><p>Van Gaalen FA, Linn-Rasker SP, van Venrooij WJ et al. Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study. Arthritis Rheum. 2004;50(3):709–15. DOI: http://dx.doi.org/10.1002%2Fart.20044.</p><p>Masson-Bessiere C, Sebbag M, Girbal-Neuhauser E et al. The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha- and beta-chains of fibrin. J Immunol. 2001;166:4177–84.</p><p>Vossenaar ER, Despres N, Lapointe E et al. Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin. Arthritis Res Ther. 2004;6:R142–50. Epub 2004 Feb 5.</p><p>Huizinga T. Genetics in rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2003;17(5):703–16. DOI: http://dx.doi.org/10.1016%2FS1521-6942%2803%2900040-8.</p><p>Symmons DP, Bankhead CR, Harrison BJ et al. Blood transfusion, smoking, and obesity as risk factors for the development of rheumatoid arthritis: results from a primary care–based incident case–control study in Norfolk, England. Arthritis Rheum. 1997;40(11):1955–61. DOI: http://dx.doi.org/10.1002%2Fart.1780401106.</p><p>Klareskog L, Alfredsson L, Rantapaa-Dahlqvist S et al. What precedes development of rheumatoid arthritis? Ann Rheum Dis. 2004;63 Suppl 2:ii28-ii31. DOI: http://dx.doi.org/10.1136%2Fard.2004.028225.</p><p>Monach PA, Benoist C, Mathis D. The role of antibodies in mouse models of rheumatoid arthritis, and relevance to human disease. Adv Immunol. 2004;82:217–48. DOI: http://dx.doi.org/10.1016%2FS0065-2776%2804%2982005-4.</p><p>Berg L, Ronnelid J, Sanjeevi CB et al. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8. Arthritis Res. 2000;2(1):75–84.</p></div><br />


Для цитирования:


Самигуллина Р.Р. Часть I. Поражение дыхательной системы у пациентов с ревматоидным артритом. Современная ревматология. 2013;7(4):62-70. https://doi.org/10.14412/1996-7012-2013-2440

For citation:


Samigullina R.R. Part I. Respiratory system involvement in patients with rheumatoid arthritis. Modern Rheumatology Journal. 2013;7(4):62-70. (In Russ.) https://doi.org/10.14412/1996-7012-2013-2440

Просмотров: 560


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 1996-7012 (Print)
ISSN 2310-158X (Online)